SpaceX Crew-13 Sets U.S. Speed Record While Bringing AI Diagnostic Tools to the Space Station
AI-guided ultrasound and a Google-backed diagnostic system are testing crew autonomy for deep space medicine

SpaceX Falcon 9 rocket lifted off from Cape Canaveral at 11:10 a.m. EDT on October 1, 2026, and seven hours and 55 minutes later, Crew Dragon Grace latched onto the forward port of the International Space Station — completing the fastest American crewed spaceflight ever recorded and delivering four astronauts to a research platform that is quietly becoming one of the most active testing grounds for autonomous AI medical technology in existence. The speed record captured the day's headlines. The work waiting for Commander Jessica Watkins and her crew once they boarded is the part that matters for where spaceflight is going.
Expedition 75 aboard the ISS has been running AI-assisted medical experiments since at least early 2026. When Crew-13 arrived on October 1, it joined an ongoing research program built around a problem that no amount of crew training or ground-based support infrastructure can fully solve: on any mission to the Moon's surface or Mars, real-time communication with physicians on Earth will either be significantly delayed or temporarily impossible. Every AI health system currently being tested on the ISS is, at its core, a rehearsal for that moment.
Crew Dragon "Grace" Completes Fastest American Crewed Flight
The record trip to the station did not come from a more powerful rocket or an upgraded engine. According to reporting on the post-docking briefing, SpaceX mission director Julianna Scheiman explained that the accelerated timeline was the product of orbital geometry, not propulsion: the space station was positioned in an opportune spot at the moment of liftoff, and the orbital mechanics worked out to produce the shortest launch-to-docking elapsed time in the history of American crewed spaceflight.
To understand why that matters, it helps to understand why ISS rendezvous missions usually take longer. After Falcon 9 delivers Crew Dragon to a low parking orbit at roughly 200 kilometers altitude, the spacecraft cannot simply climb directly to the ISS at 400 kilometers. Both vehicles are in continuous motion at approximately 28,000 kilometers per hour, and the ISS completes an orbit every 92 minutes. A standard rendezvous profile takes 24 to 28 hours, during which Dragon executes a series of precisely timed engine burns across roughly 18 orbits, gradually raising its altitude and adjusting its angular position — its "phase" — relative to the station's location in its orbit.
The fast-rendezvous profile achieves the same result in under eight hours by demanding a tighter phasing trajectory from the start. Dragon's initial orbit is set to a period slightly shorter than the ISS's, so the capsule closes the gap more quickly — but this approach requires more propellant for the phasing burns. The launch window for such a profile is narrow, and it only opens when the ISS happens to be positioned appropriately at liftoff. Crew-13 had that window; most missions do not.
Even with the unconventional trajectory, the final approach and docking are handled the same way on every Crew Dragon mission: autonomously. Dragon's onboard computer fuses data from a visual camera tracking the station's docking ring, a LIDAR (Light Detection and Ranging) sensor providing precise distance measurements, and relative GPS positioning to navigate from roughly 30 meters out through soft docking contact. Twelve latches then close in sequence, creating an airtight seal between the capsule and the Harmony module's forward port. The autonomous docking system completed this sequence on Crew-13 without a loss of control requiring manual intervention, though crew members retain full override authority at any point.
The previous U.S. crewed speed record belonged to Crew-11, which reached the ISS in 14 hours and 43 minutes in August 2025 — nearly twice the time Crew-13 needed. SpaceX's own uncrewed CRS-31 cargo Dragon had set a faster elapsed-time mark of 12 hours and 33 minutes in November 2024, but that involved an unmanned capsule with no constraints on crew comfort or abort timeline management. For comparison, Russia's Soyuz MS-17 spacecraft completed a 3-hour 3-minute rendezvous in October 2020 — the absolute record — but that was a deliberately aggressive two-orbit profile involving specific phasing conditions and trajectory choices that are not routinely applied to crew missions.
Booster B1101, which carried the Crew-13 stack, returned to Landing Zone 40 at Cape Canaveral approximately seven minutes and 40 seconds after liftoff — its third successful recovery, having previously supported the Starlink 6-88 mission and the Crew-12 mission in February 2026.
Read more: SpaceX Starship reaches orbit for the first time, delivering Starlink V3 satellites
EchoFinder-2: Augmented Reality and AI Replace the Sonographer
The most technically significant AI system currently running on the ISS is not designed to pilot spacecraft. It is designed to keep the crew alive when no doctor can help.
EchoFinder-2 is a biomedical experiment developed by the French space agency CNES and supported by ESA, combining tablet-based ultrasound hardware with augmented reality probe guidance and an AI layer that analyzes the resulting images. Its function is to allow an astronaut with no medical imaging training to perform an accurate ultrasound scan on a crewmate and receive a meaningful interpretation of the result — without any real-time ground support.
The system works in two stages. During probe positioning, the AR layer displays overlay markers on the tablet screen that guide the astronaut to place the transducer correctly on the patient's body, compensating for the lack of the tactile intuition that trained sonographers develop over years of practice. Once the probe is correctly positioned, the AI layer analyzes the acquired ultrasound image and confirms whether the target organ has been detected and visualized — removing the need for the operator to interpret the scan independently. NASA's Columbus laboratory module aboard the ISS hosted EchoFinder-2 testing throughout Expedition 74, with crew members including NASA Flight Engineer Jack Hathaway and ESA astronaut Sophie Adenot performing mutual abdominal and vascular scans under conditions in which a ground-based ultrasound technician was present remotely as an observer rather than a real-time operator.
The explicit goal of the research program is to reduce astronaut reliance on ground-based support for medical procedures as missions travel farther from Earth. The path from current testing to operational deep-space deployment requires two shifts: the AI must eventually work without any ground oversight at all, and the system's organ identification accuracy must be validated across a sufficient number of scans and crew members to establish clinical confidence. Neither condition has been publicly confirmed as met. What has been confirmed is that the technology is working well enough under controlled conditions to continue the research program.
That distinction matters when assessing what EchoFinder-2 represents. It is not a deployed diagnostic device — it is a credible research prototype being stress-tested in the only environment where testing it is meaningful: actual microgravity, aboard an actual spacecraft, with actual astronauts. No Earth-based simulation accurately captures the physical and cognitive conditions under which the system will eventually need to perform.
Microgravity imposes constraints on ultrasound imaging that are rarely encountered on Earth. Without the cues of gravitational orientation, an untrained operator scanning a colleague's abdomen must rely entirely on anatomical landmarks displayed through the AR overlay to orient the probe correctly. Gas distribution in the gut changes in weightlessness, which can shift the acoustic windows available for imaging. Fluid shifts toward the upper body alter organ position relative to surface anatomy reference points. EchoFinder-2's AR guidance layer addresses the orientation problem; whether the AI analysis layer is robust to the microgravity-induced variation in image appearance — compared to the training data it was built on, which is overwhelmingly terrestrial — is one of the core questions the ISS testing program exists to answer. Early results from NASA blog reports indicate the system is successfully identifying target organs during current testing, but no published accuracy metrics from ISS use have been made public.
NASA and Google Are Building a Space Physician That Runs on Vertex AI
EchoFinder-2 addresses one diagnostic modality: ultrasound imaging. A parallel project is attempting to address the broader clinical reasoning problem — what happens when an astronaut develops a medical problem that no imaging scan can fully resolve?
Since 2025, NASA's Human Research Program has been collaborating with Google to develop the Crew Medical Officer Digital Assistant (CMO-DA), a multimodal AI system that runs on Google Cloud's Vertex AI platform and is designed to provide differential diagnosis and treatment guidance when no physician is available and no communication with Earth is possible.
CMO-DA accepts input through speech, text, and images, allowing an astronaut to describe symptoms verbally, upload photos or scan results, and receive a structured clinical assessment. The system was trained on spaceflight medical literature, and NASA retains ownership of the application source code under a fixed-price Google Public Sector contract. In pilot testing evaluated by physicians — including at least one astronaut physician — using the Objective Structured Clinical Examination (OSCE) framework, CMO-DA achieved diagnostic accuracy of 88 percent on ankle injury scenarios, 80 percent on ear pain, and 74 percent on flank pain, according to NASA and Google.
Those figures are best described as promising research results rather than clinical benchmarks. OSCE is a validated evaluation tool used in medical school training, but performance on a standardized scenario set does not directly translate to diagnostic reliability across the unpredictable variety of conditions that could arise during a long-duration space mission. Flank pain at 74 percent is a particularly significant data point: that symptom category can indicate anything from benign muscle strain to a kidney stone to internal bleeding, and the diagnostic stakes for a misclassification in a remote environment are high. The development team has stated plans to integrate additional medical device data streams into CMO-DA and train the model to account for space medicine-specific conditions that have no terrestrial parallel — including the effects of microgravity on fluid distribution, which alters how standard clinical signs present.
CMO-DA is not a cleared medical device. It is a research tool, and NASA has not publicly announced a timeline for any clinical deployment decision.
How SpaceX's Own AI Keeps the Rocket Reliable
The AI systems aboard the ISS operate at human timescales — a medical scan takes minutes. The AI systems that got Crew-13 to the station operate at control-system timescales, making thousands of decisions per second that no human operator could replicate.
SpaceX's Falcon 9 booster uses an algorithm called G-FOLD — Guidance for Fuel-Optimal Large Diverts — to compute its own descent path during powered landing. Rather than following a pre-programmed trajectory, the system applies a technique called lossless convexification to transform the powered-descent problem into a mathematically tractable form solvable in real time. The booster continuously calculates a fuel-optimal landing path given its current velocity, position, attitude, and remaining propellant, updating the solution as conditions change during descent. The first successful demonstration of an autonomous Falcon 9 booster landing was in December 2015; the technique has since been applied to hundreds of recoveries with high reliability, including B1101's third successful return on October 1.
Crew Dragon's autonomous docking uses a different class of AI: sensor fusion and control law optimization rather than trajectory planning. During the final approach to the ISS, the capsule integrates readings from its machine vision camera, its LIDAR ranging system, and its relative GPS receiver into a single coherent model of its position and motion relative to the docking port. The control system then applies continuous small thruster firings to maintain the correct approach velocity and alignment within tolerances tight enough that the docking mechanism — which uses an international standard interface shared with other space agencies' vehicles — can complete a soft capture without structural damage. At the scale of these maneuvers, small errors compound rapidly: a docking target moving at 28,000 kilometers per hour provides essentially no margin for imprecision.
SpaceX's Starlink satellite constellation adds a third operational AI application: real-time collision avoidance. Each satellite carries the ability to ingest U.S. Department of Defense debris tracking data and autonomously decide whether to fire its krypton ion thrusters to avoid a predicted conjunction, without waiting for ground controller approval. According to regulatory filings submitted to the U.S. Federal Communications Commission, the constellation executed approximately 300,000 such avoidance maneuvers in 2025 — a figure that, even accounting for the probability that many reflected precautionary burns on relatively low-risk conjunctions, describes an autonomous decision-making load that no human operations team could handle.
The Crew-13 Astronauts and What They Will Study
Commander Jessica Watkins brings a geology doctorate from UCLA and a previous Crew-4 mission to her second Dragon flight, becoming the first active NASA astronaut to command two separate Crew Dragon missions. Watkins was selected by NASA in the 2017 astronaut class alongside Joshua Kutryk of the Canadian Space Agency, who is now making history as the first Canadian to reach the ISS through NASA's Commercial Crew Program. Kutryk had originally been assigned to a Boeing Starliner flight; after that mission was restructured to an uncrewed cargo configuration, NASA reassigned him to Dragon. The last Canadian long-duration ISS resident was David Saint-Jacques, who flew on a Russian Soyuz in December 2018.
Pilot Luke Delaney, a former naval aviator and research pilot at NASA Langley, is on his first spaceflight. Mission Specialist Sergey Teteryatnikov of Roscosmos, a former submariner who certified as a cosmonaut in 2023, is also flying for the first time. Teteryatnikov's presence reflects the ongoing NASA-Roscosmos crew exchange agreement that places one Russian cosmonaut on each Dragon crew rotation and one NASA astronaut on each Soyuz — an arrangement extended through 2027 as an operational hedge against either vehicle being temporarily grounded.
Watkins' crew joins an Expedition 75 research agenda that NASA has publicly described as including studies of in-space manufacturing techniques, augmented reality and AI methods for crew health monitoring, and bioprinting of human tissue. The physiology work is directly connected to long-duration mission planning: how cardiovascular function, bone density, and immune system performance change over months in microgravity establishes the baseline tolerances that will determine what medical support Artemis Moon crews and eventual Mars transit crews will require.
The Crew-13 arrival also carries structural significance for U.S. human spaceflight. Boeing's Starliner — originally designed to alternate ISS crew rotations with Crew Dragon under NASA's Commercial Crew Program — remains grounded following its 2024 Crew Flight Test anomalies, in which helium leaks and thruster failures led NASA to return the vehicle to Earth without its crew. NASA formally classified the incident as a Type A mishap — its most serious failure designation — in February 2026, and has since added six additional Dragon crew rotation missions to its manifest, awarding SpaceX contracts that now cover every remaining NASA crew rotation flight to the ISS. From an AI development perspective, SpaceX's dominant position has a concrete implication: Crew Dragon is the only vehicle currently capable of delivering the researchers, experimental hardware, and additional medical AI equipment that ongoing ISS AI health programs require. Any disruption to Crew Dragon operations would directly pause the only human-rated test platform for deep space medical AI currently in operation.
The ISS as AI's Most Constrained Testing Environment
The AI systems being tested inside the Columbus laboratory module — EchoFinder-2 and the research feeding into CMO-DA — face a constraint that most Earth-based AI medical applications do not: they will eventually need to operate with no connectivity, no fallback human expert, and no ability to escalate to a higher-resourced facility if the initial assessment is wrong.
On Earth, an AI diagnostic tool that achieves 74 percent accuracy on a flank pain differential is still operating in a system with multiple downstream safeguards. A physician reviews the AI's output. The patient can be transferred. A CT scanner is available. On a Mars mission, none of those safeguards exist. The communication delay between Earth and Mars ranges from approximately three minutes at closest approach to over 22 minutes when the planets are farthest apart — and during solar conjunction, when Mars passes behind the sun relative to Earth, radio communication is blocked entirely for weeks. Under those conditions, the AI diagnostic system in use is not an aid to physician decision-making; it is the physician.
That is not a critique of the systems currently being tested. It is a description of why ISS testing matters in a way that ground-based simulation cannot replicate. Every successful EchoFinder-2 scan in microgravity is data about how AI-guided probe positioning behaves when the operator's vestibular system gives no reliable gravity cues. Every successful CMO-DA pilot case is evidence about whether a multimodal language model can maintain coherent clinical reasoning when the symptoms it is evaluating present differently in spaceflight than in the terrestrial training literature on which it was trained.
The Crew-13 astronauts are joining that research program for approximately six months. What they learn — and what the AI systems learn from their cases — will directly shape the medical autonomy architecture of any human mission beyond low Earth orbit.
Read more: Chinese AI startup advances skull-barrier ultrasound imaging
What Comes After Crew-13: AI on the Path to the Moon
NASA's Artemis program has lunar surface operations as its near-term human exploration target, with long-duration stays eventually planned at the lunar Gateway outpost. Communication delays to the Moon are shorter than to Mars — approximately 1.3 seconds one-way — but intermittent coverage gaps and operational independence requirements make real-time physician consultation impractical for surface operations. The medical AI systems being validated on the ISS with Crew-13 and subsequent crews are explicitly designed to meet the autonomy threshold that Artemis surface operations will require.
The timeline for CMO-DA to move from research tool to mission-qualified system has not been publicly announced. EchoFinder-2's path to certification for clinical use on a crewed mission involves additional validation data that the ongoing ISS testing program is intended to provide. Both systems will need to demonstrate reliability not just on the specific scenarios tested in current pilots, but across the broader, messier distribution of conditions that actual crew health events follow — which is precisely the kind of validation that cannot be compressed and that can only happen in flight.
What the October 1 launch most concretely represents, then, is not a speed record or a geopolitical milestone for Canadian commercial spaceflight, though it is both of those. It is the arrival of four more humans in the only place where the question of whether AI can provide adequate medical care in the absence of any human physician can be tested under conditions that actually matter. The answer to that question will determine how far humans can safely go.